Two-Year trial tests daily pill for chronic joint and skin disease
NCT ID NCT07286058
Summary
This study aims to learn about the long-term safety and effectiveness of a daily pill called zasocitinib for adults with active psoriatic arthritis, a condition that causes joint pain and skin issues. It is a continuation study for about 1,200 people who completed a previous one-year trial. Participants will take the pill daily for up to two years so researchers can monitor their health and see how well the treatment continues to work.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSORIATIC ARTHRITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
First OC Dermatology Research Inc.
RECRUITINGFountain Valley, California, 92708, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.